European Respiratory Journal · 1998 · 433 citations · 10 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryPulmonary Drug DeliveryAerosol TherapyInhalation Drug DeliveryInhalation TherapyLung DepositionLung TargetingMetered-dose InhalersCentral Airway DepositionDrug Formulation For InhalationMetered-dose Inhaler DepositionMetered-dose Inhaler UseNebulized Drug DepositionOropharyngeal DepositionPressurized Metered Dose InhalersRegional Lung Deposition
Hydrofluoroalkane-134a (HFA) beclomethasone dipropionate (BDP) was formulated in a metered-dose inhaler (MDI) to deliver a particle size of 1.1 microm compared with 35 microns for currently marketed chlorofluorocarbon (CFC)-BDP products. Two phase I single-dose human deposition studies were conducted using technetium 99m-radiolabelled BDP in a press-and-breathe actuator without an add-on spacer. A healthy volunteer study (n=6) showed that 55-60% of the HFA-BDP ex-actuator dose was deposited in the lungs, with 29-30% deposited in the oropharynx. CFC-BDP deposition was 4-7% in the lungs and 90-94% in the oropharynx. The pattern of deposition within the lung showed that HFA-BDP was spread diffusely throughout the lung airways, whereas CFC-BDP was confined to the central airways with little, if any, peripheral airway deposition. A second study with asthmatics (n=16) confirmed that 56% of the HFA-BDP dose was deposited in the airways, with 33% in the oropharynx. In conclusion, hydrofluoroalkane-134a-beclomethasone dipropionate deposition was much greater in the airways than chlorofluorocarbon-beclomethasone dipropionate, with a concomitant reduction in oropharyngeal deposition. The increased lung deposition efficiency of the hydrofluoroalkane propellant has led to a reduction in the amount of beclomethasone dipropionate needed to achieve a similar efficacy. The penetration of the hydrofluoroalkane to the small airways may provide asthma treatment not afforded by conventional chlorofluorocarbons.
10
Alveolar Tissue Inflammation in Asthma
Monica Kraft, Ratko Djukanović, Susan J. Wilson et al. · American Journal of Respiratory and Critical Care Medicine · 1996 · 574 citations
Medicine, Immunology, Pathology +16
Deposition of pressurized suspension aerosols inhaled through extension devices.
Stanton Newman, Folke Morén, D Pavia et al. · PubMed · 1981 · 176 citations